Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.

Metabolic disorders are associated with a higher risk of psychiatric disorders. We previously reported that 20-week-old Otsuka Long-Evans Tokushima fatty (OLETF) rats, a model of progressive type 2 diabetes, showed increased anxiety-like behavior and regional area reductions and increased cholecysto...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ryosuke Ochi, Naoto Fujita, Natsuki Goto, Kaho Takaishi, Takaya Oshima, Son Tien Nguyen, Hisao Nishijo, Susumu Urakawa
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/42ce49a68d344f01aa3723b52e1bf345
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:42ce49a68d344f01aa3723b52e1bf345
record_format	dspace
spelling	oai:doaj.org-article:42ce49a68d344f01aa3723b52e1bf3452021-12-02T20:14:45ZMedial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.1932-620310.1371/journal.pone.0256655https://doaj.org/article/42ce49a68d344f01aa3723b52e1bf3452021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256655https://doaj.org/toc/1932-6203Metabolic disorders are associated with a higher risk of psychiatric disorders. We previously reported that 20-week-old Otsuka Long-Evans Tokushima fatty (OLETF) rats, a model of progressive type 2 diabetes, showed increased anxiety-like behavior and regional area reductions and increased cholecystokinin-positive neurons in the corticolimbic system. However, in which stages of diabetes these alterations in OLETF rats occur remains unclear. We aimed to investigate anxiety-like behavior and its possible mechanisms at different stages of type 2 diabetes in OLETF rats. Eight- and 30-week-old OLETF rats were used as diabetic animal models at the prediabetic and progressive stages of type 2 diabetes respectively, and age-matched Long-Evans Tokushima Otsuka rats served as non-diabetic controls. In the open-field test, OLETF rats showed less locomotion in the center zone and longer latency to leave the center zone at 8 and 30 weeks old, respectively. The areas of the medial prefrontal cortex were smaller in the OLETF rats, regardless of age. The densities of cholecystokinin-positive neurons in OLETF rats were higher in the lateral and basolateral amygdala only at 8 weeks old and in the anterior cingulate and infralimbic cortices and hippocampal cornu ammonis area 3 at both ages. The densities of parvalbumin-positive neurons of OLETF rats were lower in the cornu ammonis area 2 at 8 weeks old and in the prelimbic and infralimbic cortices at both ages. No apoptotic cell death was detected in OLETF rats, but the percentage of neurons co-expressing activating transcription factor 4 and cholecystokinin and parvalbumin was higher in OLETF rats at both ages in the anterior cingulate cortex and basolateral amygdala, respectively. These results suggest that altered emotional behavior and related neurological changes in the corticolimbic system are already present in the prediabetic stage of OLETF rats.Ryosuke OchiNaoto FujitaNatsuki GotoKaho TakaishiTakaya OshimaSon Tien NguyenHisao NishijoSusumu UrakawaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0256655 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ryosuke Ochi Naoto Fujita Natsuki Goto Kaho Takaishi Takaya Oshima Son Tien Nguyen Hisao Nishijo Susumu Urakawa Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
description	Metabolic disorders are associated with a higher risk of psychiatric disorders. We previously reported that 20-week-old Otsuka Long-Evans Tokushima fatty (OLETF) rats, a model of progressive type 2 diabetes, showed increased anxiety-like behavior and regional area reductions and increased cholecystokinin-positive neurons in the corticolimbic system. However, in which stages of diabetes these alterations in OLETF rats occur remains unclear. We aimed to investigate anxiety-like behavior and its possible mechanisms at different stages of type 2 diabetes in OLETF rats. Eight- and 30-week-old OLETF rats were used as diabetic animal models at the prediabetic and progressive stages of type 2 diabetes respectively, and age-matched Long-Evans Tokushima Otsuka rats served as non-diabetic controls. In the open-field test, OLETF rats showed less locomotion in the center zone and longer latency to leave the center zone at 8 and 30 weeks old, respectively. The areas of the medial prefrontal cortex were smaller in the OLETF rats, regardless of age. The densities of cholecystokinin-positive neurons in OLETF rats were higher in the lateral and basolateral amygdala only at 8 weeks old and in the anterior cingulate and infralimbic cortices and hippocampal cornu ammonis area 3 at both ages. The densities of parvalbumin-positive neurons of OLETF rats were lower in the cornu ammonis area 2 at 8 weeks old and in the prelimbic and infralimbic cortices at both ages. No apoptotic cell death was detected in OLETF rats, but the percentage of neurons co-expressing activating transcription factor 4 and cholecystokinin and parvalbumin was higher in OLETF rats at both ages in the anterior cingulate cortex and basolateral amygdala, respectively. These results suggest that altered emotional behavior and related neurological changes in the corticolimbic system are already present in the prediabetic stage of OLETF rats.
format	article
author	Ryosuke Ochi Naoto Fujita Natsuki Goto Kaho Takaishi Takaya Oshima Son Tien Nguyen Hisao Nishijo Susumu Urakawa
author_facet	Ryosuke Ochi Naoto Fujita Natsuki Goto Kaho Takaishi Takaya Oshima Son Tien Nguyen Hisao Nishijo Susumu Urakawa
author_sort	Ryosuke Ochi
title	Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
title_short	Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
title_full	Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
title_fullStr	Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
title_full_unstemmed	Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
title_sort	medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/42ce49a68d344f01aa3723b52e1bf345
work_keys_str_mv	AT ryosukeochi medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT naotofujita medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT natsukigoto medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT kahotakaishi medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT takayaoshima medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT sontiennguyen medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT hisaonishijo medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes AT susumuurakawa medialprefrontalareareductionsalteredexpressionsofcholecystokininparvalbuminandactivatingtranscriptionfactor4inthecorticolimbicsystemandalteredemotionalbehaviorinaprogressiveratmodeloftype2diabetes
_version_	1718374640063086592

Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.

Ejemplares similares